Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALCHEMIST
NCT01848639Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Jun 2013
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of spironolactone in end stage renal disease (ESRD), sponsored by Centre Hospitalier Universitaire de Brest. Started Jun 2013; status: completed.
02
Drugs
spironolactone
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT01848639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01848639.